Search Count: 132
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2024-11-20 Classification: TRANSFERASE Ligands: XTQ, EDO, DMS |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2024-06-12 Classification: TRANSFERASE Ligands: ZN, X8K |
![]() |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2022-10-12 Classification: TRANSFERASE Ligands: MG, DG3 |
![]() |
Crystal Structure Of Pol Theta Polymerase Domain In Complex With Compound 5
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2022-10-12 Classification: TRANSFERASE Ligands: MG, DG3, K7X |
![]() |
Crystal Structure Of Pol Theta Polymerase Domain In Complex With Compound 22
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.83 Å Release Date: 2022-10-12 Classification: TRANSFERASE Ligands: MG, DG3, K8I |
![]() |
Pgk1 In Complex With Crt0063465 (3-[2-(4-Bromophenyl)-5,7-Dimethyl-Pyrazolo[1,5-A]Pyrimidin-6-Yl]Propanoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-16 Classification: TRANSFERASE Ligands: 93T, EDO, 3PG |
![]() |
Crystal Structure Of Usp7 In Complex With The Non-Covalent Inhibitor, Ft671
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2017-10-18 Classification: HYDROLASE Ligands: 8WK |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.33 Å Release Date: 2017-10-18 Classification: HYDROLASE Ligands: 8WN, EDO |
![]() |
Crystal Structure Of Murine Autotaxin In Complex With A Small Molecule Inhibitor
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2016-11-09 Classification: HYDROLASE Ligands: NAG, 6XN, ZN, SO4, CA, NA, K, EDO |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.01 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PO4, 8R2, FDP |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PHS, PO4, F6P, S6L |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.58 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PHS, PO4, F6P, FD9 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PHS, PO4, F6P, 87T |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PHS, F6P, PO4, MJP |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2015-04-22 Classification: TRANSFERASE Ligands: PHS, PO4, F6P, 8V1 |
![]() |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2014-09-03 Classification: OXIDOREDUCTASE Ligands: NAP, 4YQ |
![]() |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
![]() |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
![]() |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |




















